Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.1B | 12.6B | 12.6B | 12.6B |
Cost of revenue | 8.2B | 9.6B | 9.5B | 9.5B |
Gross profit | 2.8B | 3.0B | 3.2B | 3.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.6B | 1.7B | 1.8B | 1.8B |
Operating income | 518.7M | 596.1M | 621.5M | 595.1M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 332.9M | 318.3M | 325.8M | 319.3M |
Other income expense | — | — | — | — |
Pretax income | 241.3M | 293.2M | 331.9M | 316.6M |
Tax provision | 132.3M | 144.4M | 74.1M | 73.3M |
Net income | 109M | 148.8M | 257.8M | 243.3M |
Basic EPS | — | 1.0 | 1.8 | 1.7 |
Diluted EPS | — | 1.0 | 1.8 | 1.7 |
Basic average shares | — | 144.5M | 144.8M | 144.8M |
Diluted average shares | — | 144.5M | 144.8M | 144.8M |
EBITDA | 706.8M | 738.1M | 793.9M | 747.8M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |